Actively Recruiting
Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients
Led by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health · Updated on 2025-06-22
30
Participants Needed
2
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Stroke remains one of the leading causes of mortality and disability worldwide. Between 30% and 40% of patients who have had an acute cerebral hemorrhage, develop unilateral spatial neglect syndrome (USN). USN is observed in 24% of patients with left-hemispheric stroke and 45% of patients with right-hemispheric lesions in the acute phase acute phase and in 20% of patients in the chronic phase. The presence of USN significantly complicates the rehabilitation process and negatively affects the functional outcomes. The complexity of USN correction is due to the heterogeneity of its manifestations and combination with other cognitive disorders. In 30-50% of patients with USN anosognosia is observed, in 60% - memory and attention disorders. Traditional methods of rehabilitation lead to significant improvement in 30-50% of patients with USN. The use of combined methods of treatment, including pharmacotherapy and non-medication methods, can improve efficacy by up to 70-80%. This indicates the need to develop and investigate new approaches to correct USN. Despite the growing number of studies in this area, there is still no unified approach to selecting the optimal method of USN correction for each individual patient. Different methods of rehabilitation may have different effects on neuroplasticity processes, which opens new perspectives for optimization of rehabilitation strategies.
CONDITIONS
Official Title
Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Normal cognitive development according to age and education level
- Diagnosis with ICD codes I63 or I61
- Presence of unilateral spatial neglect syndrome in neuropsychological assessment
You will not qualify if you...
- Severe or uncontrolled mental or physical illnesses
- Significant eye movement disorders
- Moderate to severe sensory visual defects
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Federal Center of Brain and Neurotechnologies of the FMBA of Russia
Moscow, Moscow, Russia, 117997
Actively Recruiting
2
Federal Center of Brain and Neurotechnologies of the FMBA of Russia
Moscow, Russia, 117997
Actively Recruiting
Research Team
S
Salima Eneeva
CONTACT
M
Marina Alekseevna, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here